Event

Eosinophils are a known contributor to asthma exacerbations. Reducing exacerbations is the key objective when treating patients with severe asthma. Questions remain regarding targeting blood eosinophils in patients with severe eosinophilic asthma who also have allergic markers. Come learn about new evidence from a targeted treatment that reduced the frequency of asthma exacerbations.